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Liquid biopsies offer a non-invasive alternative to tissue biopsies for both diagnosis and monitoring 
of treatment response. Over the last decade, extracellular RNAs (exRNAs) circulating in the 
bloodstream have been identified as potential biomarkers. Apart from plasma and serum, many 
other human biofluids can be collected and may contain diagnostic, prognostic or theragnostic 
biomarker potential. 
The goal of this study is to unravel the extracellular transcriptome of 22 human biofluids (amniotic 
fluid, aqueous humor, bile, bronchial lavage fluid, breast milk, cerebrospinal fluid, colostrum, gastric 
fluid, pancreatic cyst fluid, peritoneal fluid, platelet-free plasma, platelet-poor plasma, platelet-rich 
plasma, saliva, seminal fluid, serum, sputum, stool, synovial fluid, sweat, tear fluid and urine), each 
collected from at least two donors. All fluids were centrifuged and frozen within two hours after 
collection. Total RNA was isolated from the cell-free supernatant and spike-in RNA controls were 
added to enable absolute quantification of exRNAs. The RNA content was subsequently characterized 
in all biofluids using established small RNA and mRNA sequencing workflows. Analysis of the small 
RNA-sequencing data revealed the presence of small RNA species in all biofluids. Highly variable 
small RNA concentrations (up to 100 000-fold) and marked differences in RNA biotypes among 
biofluids were observed. Analysis of the mRNA profiles is currently ongoing. By applying 
computational deconvolution methods, we aim to identify the cell types and tissues that are 
contributing to the exRNA repertoire in these biofluids. These novel insights may provide a more 
rational selection of relevant biofluids for biomarker discovery in various human diseases. 
